U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07812545) titled 'Designing Effective Alcohol Health Warnings: An Experimental Study With Adults in the U.S.' on Aug. 27.

Brief Summary: Consuming alcohol is a dose-dependent and modifiable risk factor for breast cancer. Although alcohol consumption contributes to an estimated 16% of breast cancer cases, awareness of the link between alcohol and breast cancer risk remains low. Systematically developed and tested health warnings can support population-based approaches and intervention strategies to decrease alcohol consumption and breast cancer risk. For instance, the U.S. Food and Drug Administration can mandate specific warnings through statements ...